Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Agitation in Alzheimer's Dementia
NCT02168920Phase 3Terminated
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jun 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in Alzheimer's disease (AD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jun 2014; status: terminated.
02
Drugs
aripiprazole
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02168920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168920.